US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals
Watchlist
17.060
+0.250+1.49% Close 12/04 16:00 ET
17.0600.0000.00%
Post 16:20 ET
17.090High16.470Low271.64KVolume
16.650Open16.810Pre Close4.59MTurnover0.90%Turnover RatioLossP/E (TTM)1.20BMarket Cap20.65052wk High6.56P/E (Static)70.34MShares10.29052wk Low2.96P/B513.17MFloat Cap32.880Historical High--Dividend TTM30.08MShs Float5.010Historical Low--Div YieldTTM3.69%Amplitude16.894Avg Price1Lot Size
Kiniksa Pharmaceuticals Key Stats
EPS
According to the latest financial report of Kiniksa Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.20. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Kiniksa Pharmaceuticals's free cash flow? The latest report shows it as 16.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Kiniksa Pharmaceuticals shows that the company's current ratio is 4.79, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Kiniksa Pharmaceuticals, the quick ratio is 3.82, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of Kiniksa Pharmaceuticals? The latest ROE figure is -3.39%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Kiniksa Pharmaceuticals, the total asset return on investment (ROA) is -2.86%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Kiniksa Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 60.63%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Kiniksa Pharmaceuticals, the net profit margin is -20.66%, which is a good sign for its profitability.
Quarterly
Loading...
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--